Goldman Sachs Group Inc. Sells 85,577 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Goldman Sachs Group Inc. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 10.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 773,954 shares of the company’s stock after selling 85,577 shares during the period. Goldman Sachs Group Inc. owned approximately 0.60% of Henry Schein worth $58,596,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of HSIC. Aurora Investment Counsel grew its stake in Henry Schein by 0.7% during the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after buying an additional 140 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after acquiring an additional 149 shares during the last quarter. Crossmark Global Holdings Inc. increased its holdings in shares of Henry Schein by 1.5% during the fourth quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock valued at $991,000 after acquiring an additional 197 shares in the last quarter. Wahed Invest LLC raised its position in shares of Henry Schein by 11.3% in the 3rd quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock valued at $151,000 after purchasing an additional 206 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its stake in Henry Schein by 0.4% in the 3rd quarter. Treasurer of the State of North Carolina now owns 66,473 shares of the company’s stock worth $4,936,000 after purchasing an additional 242 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ:HSIC opened at $68.28 on Wednesday. The company has a 50 day moving average price of $70.70 and a 200-day moving average price of $73.19. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a market cap of $8.74 billion, a price-to-earnings ratio of 23.07, a price-to-earnings-growth ratio of 1.62 and a beta of 0.90. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. During the same quarter in the previous year, the company earned $1.21 earnings per share. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. Equities research analysts forecast that Henry Schein, Inc. will post 5.17 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. Barrington Research lifted their price target on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. SVB Leerink assumed coverage on Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price objective on the stock. Evercore ISI lifted their target price on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. Finally, UBS Group cut their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $81.73.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.